
Clinic and outcomes of viral hepatitis A and B with parenteral transmission
Author(s) -
Д. К. Баширова,
Д. Ш. Еналеева,
M. S. Fatkulov,
Ya. Kh. Sadekova
Publication year - 1989
Publication title -
kazanskij medicinskij žurnal
Language(s) - English
Resource type - Journals
eISSN - 2587-9359
pISSN - 0368-4814
DOI - 10.17816/kazmj99840
Subject(s) - viral hepatitis , virology , transmission (telecommunications) , medicine , incidence (geometry) , hepatitis , hepatitis b , viral disease , disease , hepatitis c , serology , immunology , virus , antibody , computer science , telecommunications , physics , optics
Viral hepatitis A or B is one of the least studied. Its incidence varies in Europe from 14 to 40%. In Moscow, according to the Institute of Virology named after D.I. Ivanovsky of the USSR Academy of Medical Sciences, it accounts for 15-20%. The term "viral hepatitis neither A nor B" is usually used to refer to a disease caused by an agent having no serological similarity with the causative agent of viral hepatitis A or B. However, all nosological forms of viral hepatitis are characterized by similar clinical symptoms of biochemical changes, which makes their identification difficult.